Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.64 USD
Change Today +0.18 / 5.20%
Volume 24.6K
ADMP On Other Exchanges
Symbol
Exchange
NASDAQ CM
Stuttgart
As of 5:20 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Dennis J. Carlo Ph.D.

Chief Executive Officer, President and Director,Adamis Pharmaceuticals Corporation
AgeTotal Calculated CompensationThis person is connected to 4 board members in 1 different organizations across 2 different industries.

See Board Relationships
72$819,361
As of Fiscal Year 2014

Background*

Mr. Dennis J. Carlo, Ph.D. has been the Chief Executive Officer and President of Adamis Pharmaceuticals Corporation since April 2009. Dr. Carlo was a co-founder of Old Adamis and served as its President and Chief Executive Officer from October 2006 to April 2009. He served as the Chief Executive Officer and President of Cellegy Pharmaceuticals Inc. He co-founded Immune Response Corporation and also served as its President and Chief Executive Officer from September 1994 ...

Read Full Background

Corporate Headquarters*

11682 El Camino Real
San Diego, California 92130

United States

Phone: 858-997-2400
Fax: --

Board Members Memberships*

2009-Present
Chief Executive Officer, President and Director

Education*

MS
The Ohio State University
PhD
The Ohio State University
BS
The Ohio State University

Other Affiliations*

Annual Compensation*

Salary$393,750
Bonus$160,000
Total Annual Compensation$553,750

Stock Options*

All Other Compensation$15,480
Exercisable Options179,689
Total Number of Options179,689

Total Compensation*

Total Annual Cash Compensation$569,230
Total Short Term Compensation$553,750
Other Long Term Compensation$15,480
Total Calculated Compensation$819,361
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ADMP:US $3.64 USD +0.18

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jennifer K. Simpson Ph.D., M.S.N., C.R.N.P.Chief Executive Officer and President
Delcath Systems, Inc.
$401.3K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ADAMIS PHARMACEUTICALS CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.